Free Access
Med Sci (Paris)
Volume 38, Number 11, Novembre 2022
Page(s) 897 - 904
Section M/S Revues
Published online 30 November 2022
  1. Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017 ; 102 : 3869–3903. [CrossRef] [PubMed] [Google Scholar]
  2. Spack NP, Edwards-Leeper L, Feldman HA, et al. Children and adolescents with gender identity disorder referred to a pediatric medical center. Pediatrics 2012 ; 129 : 418–425. [CrossRef] [PubMed] [Google Scholar]
  3. Khatchadourian K, Amed S, Metzger DLClinical management of youth with gender dysphoria in Vancouver. J Pediatr 2014 ; 164 : 906–911. [CrossRef] [PubMed] [Google Scholar]
  4. Skordis N, Butler G, de Vries MC, et al. ESPE and PES International Survey of Centers and Clinicians Delivering Specialist Care for Children and Adolescents with Gender Dysphoria. Horm Res Paediatr 2018 ; 90 : 326–331. [CrossRef] [PubMed] [Google Scholar]
  5. Zucker KJEpidemiology of gender dysphoria and transgender identity. Sex Health 2017 ; 14 : 404–411. [CrossRef] [PubMed] [Google Scholar]
  6. Steensma TD, Biemond R, de Boer F, et al. Desisting and persisting gender dysphoria after childhood: a qualitative follow-up study. Clin Child Psychol Psychiatry 2011 ; 16 : 499–516. [CrossRef] [PubMed] [Google Scholar]
  7. Olson KR, Durwood L, Horton R, et al. Gender Identity 5 Years After Social Transition. Pediatrics 2022; 150 : e2021056082. [CrossRef] [PubMed] [Google Scholar]
  8. de Vries ALC, Steensma TD, Doreleijers TAH, et al. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study. J Sex Med 2011 ; 8 : 2276–2283. [CrossRef] [PubMed] [Google Scholar]
  9. Cohen-Kettenis PT, Klink DAdolescents with gender dysphoria. Best Pract Res Clin Endocrinol Metab 2015 ; 29 : 485–495. [CrossRef] [PubMed] [Google Scholar]
  10. Cohen-Kettenis PT, Owen A, Kaijser VG, et al. Demographic characteristics, social competence, and behavior problems in children with gender identity disorder: a cross-national, cross-clinic comparative analysis. J Abnorm Child Psychol 2003 ; 31 : 41–53. [CrossRef] [PubMed] [Google Scholar]
  11. World Professional Association for Transgender Health (WPATH) Standards of Care, 7th version (2012). [Google Scholar]
  12. Kaltiala-Heino R, Sumia M, Työläjärvi M, et al. Two years of gender identity service for minors: overrepresentation of natal girls with severe problems in adolescent development. Child Adolesc Psychiatry Ment Health 2015 ; 9 : 9. [CrossRef] [PubMed] [Google Scholar]
  13. de Vries ALC, Doreleijers TAH, Steensma TD, et al. Psychiatric comorbidity in gender dysphoric adolescents. J Child Psychol Psychiatry 2011 ; 52 : 1195–1202. [CrossRef] [PubMed] [Google Scholar]
  14. Thoma BC, Salk RH, Choukas-Bradley S, et al. Suicidality Disparities Between Transgender and Cisgender Adolescents. Pediatrics 2019 ; 144 [PubMed] [Google Scholar]
  15. Warrier V, Greenberg DM, Weir E, et al. Elevated rates of autism, other neurodevelopmental and psychiatric diagnoses, and autistic traits in transgender and gender-diverse individuals. Nat Commun 2020; 11 : 3959. [CrossRef] [PubMed] [Google Scholar]
  16. Eisenberg ME, Gower AL, McMorris BJ, et al. Risk and Protective Factors in the Lives of Transgender/Gender Nonconforming Adolescents. J Adolesc Health 2017 ; 61 : 521–526. [CrossRef] [PubMed] [Google Scholar]
  17. D’hoore L, T’Sjoen G. Gender-affirming hormone therapy: An updated literature review with an eye on the future. J Intern Med 2022; 291 : 574–92. [CrossRef] [PubMed] [Google Scholar]
  18. American Psychological AssociationGuidelines for psychological practice with transgender and gender nonconforming people. Am Psychol 2015 ; 70 : 832–864. [CrossRef] [PubMed] [Google Scholar]
  19. Olson KR, Durwood L, DeMeules M, et al. Mental Health of Transgender Children Who Are Supported in Their Identities. Pediatrics 2016 ; 137 : e20153223. [CrossRef] [PubMed] [Google Scholar]
  20. Durwood L, McLaughlin KA, Olson KRMental Health and Self-Worth in Socially Transitioned Transgender Youth. J Am Acad Child Adolesc Psychiatry 2017 ; 56 : 116–23e2. [CrossRef] [PubMed] [Google Scholar]
  21. Turban JLTransgender Youth: The Building Evidence Base for Early Social Transition. J Am Acad Child Adolesc Psychiatry 2017 ; 56 : 101–102. [CrossRef] [PubMed] [Google Scholar]
  22. Cohen-Kettenis PTDelemarre-van de Waal HA, Gooren LJG. The treatment of adolescent transsexuals: changing insights. J Sex Med 2008 ; 5 : 1892–1897. [CrossRef] [PubMed] [Google Scholar]
  23. Mahfouda S, Moore JK, Siafarikas A, et al. Gender-affirming hormones and surgery in transgender children and adolescents. Lancet Diabetes Endocrinol 2019 ; 7 : 484–498. [CrossRef] [PubMed] [Google Scholar]
  24. Olson-Kennedy J, Warus J, Okonta V, et al. Chest Reconstruction and Chest Dysphoria in Transmasculine Minors and Young Adults: Comparisons of Nonsurgical and Postsurgical Cohorts. JAMA Pediatr 2018 ; 172 : 431–436. [CrossRef] [PubMed] [Google Scholar]
  25. Schagen SEE, Cohen-Kettenis PT, Delemarre-van de Waal HA, et al. Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents. J Sex Med 2016 ; 13 : 1125–1132. [CrossRef] [PubMed] [Google Scholar]
  26. Martinerie L, Condat A, Bargiacchi A, et al. Management of endocrine disease: Approach to the management of children and adolescents with Gender Dysphoria. Eur J Endocrinol 2018 ; 179 : R219–R237. [CrossRef] [PubMed] [Google Scholar]
  27. Olson-Kennedy J, Chan Y-M, Garofalo R, et al. Impact of Early Medical Treatment for Transgender Youth: Protocol for the Longitudinal, Observational Trans Youth Care Study. JMIR Res Protoc 2019 ; 8 : e14434. [CrossRef] [PubMed] [Google Scholar]
  28. Mahfouda S, Moore JK, Siafarikas A, et al. Puberty suppression in transgender children and adolescents. Lancet Diabetes Endocrinol 2017 ; 5 : 816–826. [CrossRef] [PubMed] [Google Scholar]
  29. Carmichael P, Butler G, Masic U, et al. Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK. PLoS One 2021; 16 : e0243894. [CrossRef] [PubMed] [Google Scholar]
  30. Carel J-C, Eugster EA, Rogol A, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009 ; 123 : e752–e762. [CrossRef] [PubMed] [Google Scholar]
  31. Manasco PK, Pescovitz OH, Feuillan PP, et al. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. J Clin Endocrinol Metab 1988 ; 67 : 368–372. [CrossRef] [PubMed] [Google Scholar]
  32. Klink D, Caris M, Heijboer A, et al. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria. J Clin Endocrinol Metab 2015 ; 100 : E270–E275. [CrossRef] [PubMed] [Google Scholar]
  33. Vlot MC, Klink DT, den Heijer M, et al. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents. Bone 2017 ; 95 : 11–19. [CrossRef] [PubMed] [Google Scholar]
  34. Grift TC van de, Gelder ZJ van, Mullender MG, et al. Timing of Puberty Suppression and Surgical Options for Transgender Youth. Pediatrics 2020; 146 : e20193653. [CrossRef] [PubMed] [Google Scholar]
  35. de Vries ALC, McGuire JK, Steensma TD, et al. Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics 2014 ; 134 : 696–704. [CrossRef] [PubMed] [Google Scholar]
  36. Hannema SE, Schagen SEE, Cohen-Kettenis PT, et al. Efficacy and Safety of Pubertal Induction Using 17β-Estradiol in Transgirls. J Clin Endocrinol Metab 2017 ; 102 : 2356–2363. [PubMed] [Google Scholar]
  37. Tack LJW, Heyse R, Craen M, et al. Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents. J Sex Med 2017 ; 14 : 747–757. [CrossRef] [PubMed] [Google Scholar]
  38. Klaver M, de Mutsert R, Wiepjes CM, et al. Early Hormonal Treatment Affects Body Composition and Body Shape in Young Transgender Adolescents. J Sex Med 2018 ; 15 : 251–260. [CrossRef] [PubMed] [Google Scholar]
  39. Tack LJW, Craen M, Dhondt K, et al. Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis. Biol Sex Differ 2016 ; 7 : 14. [CrossRef] [PubMed] [Google Scholar]
  40. Jarin J, Pine-Twaddell E, Trotman G, et al. Cross-Sex Hormones and Metabolic Parameters in Adolescents With Gender Dysphoria. Pediatrics 2017 ; 139 : e20163173. [CrossRef] [PubMed] [Google Scholar]
  41. Butler G, Adu-Gyamfi K, Clarkson K, et al. Discharge outcome analysis of 1089 transgender young people referred to paediatric endocrine clinics in England 2008–2021. Arch Dis Child 2022; archdischild-2022-324302. [PubMed] [Google Scholar]
  42. Wiepjes CM, Nota NM, de Blok CJM, et al. The Amsterdam Cohort of Gender Dysphoria Study (1972–2015): Trends in Prevalence, Treatment, and Regrets. J Sex Med 2018 ; 15 : 582–590. [CrossRef] [PubMed] [Google Scholar]
  43. Turban JL, Beckwith N, Reisner SL, et al. Association Between Recalled Exposure to Gender Identity Conversion Efforts and Psychological Distress and Suicide Attempts Among Transgender Adults. JAMA Psychiatry 2020; 77 : 68–76. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.